Celastrol alleviates esophageal stricture in rats by inhibiting NLR family pyrin domain containing 3 activation
World Journal of Gastroenterology · 2025
DOI: 10.3748/wjg.v31.i23.106949 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, 2025. Verfasst von Miao-Xin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji H…. Hauptthemen laut MEDLINE: Pentacyclic Triterpenes, NLR Family, Pyrin Domain-Containing 3 Protein, Esophageal Stenosis, Triterpenes. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND The role of NLR family pyrin domain containing 3 (NLRP3) in post-endoscopic submucosal dissection (ESD) esophageal stricture remains incompletely understood. The effect of celastrol (CEL) on the prevention of esophageal strictures has not yet been investigated. AIM To explore the effect of CEL on the prevention of esophageal stricture in rats. METHODS NLRP3, interleukin (IL)-1β, and IL-18 mRNA levels were measured in patients’ tissues after esophageal ESD. NLRP3 expression in esophageal fibroblasts was determined using immunohistochemistry and immunofluorescence staining. Lentiviral transfection was used to induce NLRP3 overexpression and thioredoxin reductase 1 (TXNRD1) silencing. The CCK8 assay was used to determine the optimal CEL concentration. Reactive oxygen species (ROS) generation was detected via fluorescence and flow cytometry. Masson’s trichrome staining and barium esophagography were performed to assess collagen deposition and esophageal stenosis. RESULTS The mRNA levels of NLRP3 and IL-1β were higher in human tissues from the ESD resection bed than in normal esophageal mucosa. NLRP3 overexpression in primary rat esophageal fibroblasts led to high collagen 1 expression. Thus, NLRP3 participated in esophageal inflammation and tissue repair after ESD. Comparable to prednisolone, CEL significantly inhibited NLRP3 activation in vitro and in vivo , and esophageal strictures were markedly alleviated. Mechanistically, CEL upregulated TXNRD1 expression and reduced ROS production, thereby inhibiting NLRP3 expression. This effect was reversed by TXNRD1 silencing. Furthermore, TXNRD1 interacted with NLRP3 and promoted its ubiquitination. CONCLUSION CEL is a promising alternative therapeutic agent for the prevention of post-ESD esophageal strictures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Institute of Liver and Gastrointestinal Diseases, Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital of Tongji Medical College, Huazhong University of Science and…
- Department of Gastroenterology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China.
Zitieren
APA
Zhang, M. X., Wu, C., Feng, X. X., Tian, W., Zhao, N. H., Lu, P. P., Ding, Q., & Liu, M. (2025). Celastrol alleviates esophageal stricture in rats by inhibiting NLR family pyrin domain containing 3 activation. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v31.i23.106949
Vancouver
Zhang MX, Wu C, Feng XX, Tian W, Zhao NH, Lu PP, et al. Celastrol alleviates esophageal stricture in rats by inhibiting NLR family pyrin domain containing 3 activation. World Journal of Gastroenterology. 2025. doi:10.3748/wjg.v31.i23.106949
BibTeX
@article{Zhang2025,
author = {Zhang, Miao-Xin and Wu, Chi and Feng, Xin-Xia and Tian, Wei and Zhao, Ning-Hui and Lu, Pan-Pan and Ding, Qiang and Liu, Mei},
title = {Celastrol alleviates esophageal stricture in rats by inhibiting NLR family pyrin domain containing 3 activation},
journal = {World Journal of Gastroenterology},
year = {2025},
doi = {10.3748/wjg.v31.i23.106949}
}
EUVIMED